Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × tivozanib × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 2 Carcinoma, Renal Cell 2 Bile Duct Neoplasms 2 Vulvar Neoplasms 1 Sarcoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1

Interventions

pembrolizumab 5 Injections 4 Bevacizumab 4 Pemetrexed 3 Oxaliplatin 3 Leucovorin 3 Fluorouracil 3 Docetaxel 3 Carboplatin 3 trifluridine tipiracil drug combination 2 Paclitaxel 2 Irinotecan 2 Cetuximab 2 tislelizumab 1 sotorasib 1 palbociclib 1 olaparib 1 netrin-1 inhibitor NP137 1 fludarabine 1 cemiplimab 1 Panitumumab 1 Nivolumab 1 Itraconazole 1 HMPL-013 1 Fulvestrant 1 Etoposide 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡